BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31062525)

  • 1. The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01.
    Kim YZ; Kim CY; Lim J; Sung KS; Lee J; Oh HJ; Kang SG; Kang SH; Kong DS; Kim SH; Kim SH; Kim SH; Kim YJ; Kim EH; Kim IA; Kim HS; Roh TH; Park JS; Park HJ; Song SW; Yang SH; Yoon WS; Yoon HI; Lee ST; Lee SW; Lee YS; Wee CW; Chang JH; Jung TY; Jung HL; Cho JH; Choi SH; Choi HS; Hong JB; Lim DH; Chung DS;
    Brain Tumor Res Treat; 2019 Apr; 7(1):1-9. PubMed ID: 31062525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01.
    Kim YZ; Kim CY; Lim J; Sung KS; Lee J; Oh HJ; Kang SG; Kang SH; Kong DS; Kim SH; Kim SH; Kim SH; Kim YJ; Kim EH; Kim IA; Kim HS; Roh TH; Park JS; Park HJ; Song SW; Yang SH; Yoon WS; Yoon HI; Lee ST; Lee SW; Lee YS; Wee CW; Chang JH; Jung TY; Jung HL; Cho JH; Choi SH; Choi HS; Hong JB; Lim DH; Chung DS;
    Brain Tumor Res Treat; 2019 Oct; 7(2):63-73. PubMed ID: 31686436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01.
    Kim YZ; Kim CY; Wee CW; Roh TH; Hong JB; Oh HJ; Kang SG; Kang SH; Kong DS; Kim SH; Kim SH; Kim SH; Kim YJ; Kim EH; Kim IA; Kim HS; Park JS; Park HJ; Song SW; Sung KS; Yang SH; Yoon WS; Yoon HI; Lee J; Lee ST; Lee SW; Lee YS; Lim J; Chang JH; Jung TY; Jung HL; Cho JH; Choi SH; Choi HS; Lim DH; Chung DS;
    Brain Tumor Res Treat; 2019 Oct; 7(2):74-84. PubMed ID: 31686437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1.
    Yoon HI; Wee CW; Kim YZ; Seo Y; Im JH; Dho YS; Kim KH; Hong JB; Park JS; Choi SH; Kim MS; Moon J; Hwang K; Park JE; Cho JM; Yoon WS; Kim SH; Kim YI; Kim HS; Sung KS; Song JH; Lee MH; Han MH; Lee SH; Chang JH; Lim DH; Park CK; Lee YS; Gwak HS;
    Brain Tumor Res Treat; 2021 Apr; 9(1):1-8. PubMed ID: 33913265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Survey About Specific Clinical Scenarios (Version 2023.1).
    Kim MS; Go SI; Wee CW; Lee MH; Kang SG; Go KO; Kwon SM; Kim W; Dho YS; Park SH; Seo Y; Song SW; Ahn S; Oh HJ; Yoon HI; Lee SW; Lee JH; Cho KR; Choi JW; Hong JB; Hwang K; Park CK; Lim DH;
    Brain Tumor Res Treat; 2023 Apr; 11(2):133-139. PubMed ID: 37151155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic Drug Usage of Brain Tumor: Version 2021.1.
    Moon J; Kim MS; Kim YZ; Hwang K; Park JE; Kim KH; Cho JM; Yoon WS; Kim SH; Kim YI; Kim HS; Dho YS; Park JS; Yoon HI; Seo Y; Sung KS; Song JH; Wee CW; Lee MH; Han MH; Hong JB; Im JH; Lee SH; Chang JH; Lim DH; Park CK; Lee YS; Gwak HS;
    Brain Tumor Res Treat; 2021 Apr; 9(1):9-15. PubMed ID: 33913266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Recommendation Using the Delphi Method (Version 2023.1).
    Kim MS; Go SI; Wee CW; Lee MH; Kang SG; Go KO; Kwon SM; Kim W; Dho YS; Park SH; Seo Y; Song SW; Ahn S; Oh HJ; Yoon HI; Lee SW; Lee JH; Cho KR; Choi JW; Hong JB; Hwang K; Park CK; Lim DH;
    Brain Tumor Res Treat; 2023 Apr; 11(2):123-132. PubMed ID: 37151154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.
    Sulman EP; Ismaila N; Armstrong TS; Tsien C; Batchelor TT; Cloughesy T; Galanis E; Gilbert M; Gondi V; Lovely M; Mehta M; Mumber MP; Sloan A; Chang SM
    J Clin Oncol; 2017 Jan; 35(3):361-369. PubMed ID: 27893327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO.
    Kim YZ; Kim CY; Lim DH
    Brain Tumor Res Treat; 2022 Apr; 10(2):83-93. PubMed ID: 35545827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma.
    Kim SK; Yoon HI; Yoon WS; Cho JM; Moon J; Kim KH; Kim SH; Kim YI; Kim YZ; Kim HS; Dho YS; Park JS; Park JE; Seo Y; Sung KS; Song JH; Wee CW; Lee SH; Lim DH; Im JH; Chang JH; Han MH; Hong JB; Hwang K; Park CK; Lee YS; Gwak HS;
    Brain Tumor Res Treat; 2020 Apr; 8(1):11-19. PubMed ID: 32390349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.
    Biau J; Chautard E; De Schlichting E; Dupic G; Pereira B; Fogli A; Müller-Barthélémy M; Dalloz P; Khalil T; Dillies AF; Durando X; Godfraind C; Verrelle P
    Radiat Oncol; 2017 Dec; 12(1):197. PubMed ID: 29212499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.
    Kim BS; Seol HJ; Nam DH; Park CK; Kim IH; Kim TM; Kim JH; Cho YH; Yoon SM; Chang JH; Kang SG; Kim EH; Suh CO; Jung TY; Lee KH; Kim CY; Kim IA; Hong CK; Yoo H; Kim JH; Kang SH; Kang MK; Kim EY; Kim SH; Chung DS; Hwang SC; Song JH; Cho SJ; Lee SI; Lee YS; Ahn KJ; Kim SH; Lim DH; Gwak HS; Lee SH; Hong YK
    Cancer Res Treat; 2017 Jan; 49(1):193-203. PubMed ID: 27384161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).
    Scoccianti S; Krengli M; Marrazzo L; Magrini SM; Detti B; Fusco V; Pirtoli L; Doino D; Fiorentino A; Masini L; Greto D; Buglione M; Rubino G; Lonardi F; Migliaccio F; Marzano S; Santoni R; Ricardi U; Livi L
    Radiol Med; 2018 Jan; 123(1):48-62. PubMed ID: 28879459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A National Consensus Survey for Current Practice in Brain Tumor Management III: Brain Metastasis and Primary Central Nervous System Lymphoma.
    Kim SK; Park JE; Kim KH; Cho JM; Moon J; Yoon WS; Kim SH; Kim YI; Kim YZ; Kim HS; Dho YS; Park JS; Yoon HI; Seo Y; Sung KS; Song JH; Wee CW; Lee SH; Lim DH; Im JH; Chang JH; Han MH; Hong JB; Hwang K; Park CK; Lee YS; Gwak HS;
    Brain Tumor Res Treat; 2020 Apr; 8(1):20-28. PubMed ID: 32390350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma in the elderly: initial management.
    de Moraes FY; Laperriere N
    Chin Clin Oncol; 2017 Aug; 6(4):39. PubMed ID: 28841801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma care in the elderly.
    Jordan JT; Gerstner ER; Batchelor TT; Cahill DP; Plotkin SR
    Cancer; 2016 Jan; 122(2):189-97. PubMed ID: 26618888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
    Saito T; Sugiyama K; Takeshima Y; Amatya VJ; Yamasaki F; Takayasu T; Nosaka R; Muragaki Y; Kawamata T; Kurisu K
    J Neurosurg; 2018 Mar; 128(3):679-684. PubMed ID: 28430038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy of Glioblastoma 15 Years after the Landmark Stupp's Trial: More Controversies than Standards?
    Kazda T; Dziacky A; Burkon P; Pospisil P; Slavik M; Rehak Z; Jancalek R; Slampa P; Slaby O; Lakomy R
    Radiol Oncol; 2018 Jun; 52(2):121-128. PubMed ID: 30018514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What type of adjuvant chemotherapy should be proposed for the initial treatment of glioblastoma?].
    Ducray F; Honnorat J
    Presse Med; 2007 Sep; 36(9 Pt 2):1249-54. PubMed ID: 17350791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.